Ginger capsule and frankincense effect on uterine hemorrhage

Phase 2

• Conditions: Heavy menstrual bleeding.; Excessive and frequent menstruation with regular cycle

• Registration Number: IRCT2016062228579N1
• Lead Sponsor: Vice chacellor for research, Isfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 90

Inclusion Criteria

Outpatient women at the age of 18-45years; Regular 22- 35 day menstrual cycles; presence of menorrhagia based on Higham bleeding assessment chart (bleeding more than 80 ml per cycle, or more than 7 days); absence of moderate or severe anemia (hemoglobin greater than 10.5 milligrams per deciliter); The absence of uterine fibroma or being smaller than 5 cm; The absence of ovarian cysts; Not using hormonal drugs or any medication affecting menstrual bleeding (oral contraceptive pills and aspirin, warfarin); normal endometrial thickness in abdominal or trans vaginal ultrasound; The patient is not pregnant or during lactation.
Exclusion criteria: pregnancy; breast feeding; taking hormonal drugs or mefenamic acid during their menstruation period; being allergic to ginger or frankincense; severe bleeding during menstruation period requiring emergency measures.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Menstrual blood volume. Timepoint: The end of each menstrual cycle. Method of measurement: Pictorial Blood Loss Assessment (PBAC).;Time period (days) of menstrual bleeding. Timepoint: The end of each menstrual cycle. Method of measurement: Pictorial Blood Loss Assessment (PBAC).